View Item 

Show simple item record

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
dc.contributor.authorBerti, Alvise
dc.contributor.authorWarner, Roscoe
dc.contributor.authorJohnson, Kent
dc.contributor.authorCornec, Divi
dc.contributor.authorSchroeder, Darrell
dc.contributor.authorKabat, Brian
dc.contributor.authorLangford, Carol A.
dc.contributor.authorHoffman, Gary S.
dc.contributor.authorFervenza, Fernanado C.
dc.contributor.authorKallenberg, Cees G. M.
dc.contributor.authorSeo, Philip
dc.contributor.authorSpiera, Robert
dc.contributor.authorSt.Clair, E. William
dc.contributor.authorBrunetta, Paul
dc.contributor.authorStone, John H.
dc.contributor.authorMerkel, Peter A.
dc.contributor.authorSpecks, Ulrich
dc.contributor.authorMonach, Paul A.
dc.date.accessioned2018-07-13T15:47:34Z
dc.date.available2019-09-04T20:15:39Zen
dc.date.issued2018-07
dc.identifier.citationBerti, Alvise; Warner, Roscoe; Johnson, Kent; Cornec, Divi; Schroeder, Darrell; Kabat, Brian; Langford, Carol A.; Hoffman, Gary S.; Fervenza, Fernanado C.; Kallenberg, Cees G. M.; Seo, Philip; Spiera, Robert; St.Clair, E. William; Brunetta, Paul; Stone, John H.; Merkel, Peter A.; Specks, Ulrich; Monach, Paul A. (2018). "Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis." Arthritis & Rheumatology 70(7): 1114-1121.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/144646
dc.publisherWiley Periodicals, Inc.
dc.titleBrief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/144646/1/art40471_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/144646/2/art40471.pdf
dc.identifier.doi10.1002/art.40471
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferenceLyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA‐associated vasculitis. N Engl J Med 2012; 367: 214 – 23.
dc.identifier.citedreferenceCornec D, Cornec‐Le Gall E, Fervenza FC, Specks U. ANCA‐associated vasculitis: clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 2016; 12: 570 – 9.
dc.identifier.citedreferenceHogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody‐associated small‐vessel vasculitis. Ann Int Med 2005; 143: 621 – 31.
dc.identifier.citedreferenceUnizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, et al. Clinical outcomes of treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis based on ANCA type. Ann Rheum Dis 2016; 75: 1166 – 9.
dc.identifier.citedreferenceJennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 2013; 65: 1 – 11.
dc.identifier.citedreferenceRonnblom L, Eloranta ML. The interferon signature in autoimmune diseases. Curr Opin Rheumatol 2013; 25: 248 – 53.
dc.identifier.citedreferenceCornec D, Berti A, Hummel A, Peikert T, Pers JO, Specks U. Identification and phenotyping of circulating autoreactive proteinase 3‐specific B cells in patients with PR3‐ANCA associated vasculitis and healthy controls. J Autoimmun 2017; 84: 122 – 31.
dc.identifier.citedreferenceSpecks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, et al. Efficacy of remission‐induction regimens for ANCA‐associated vasculitis. N Engl J Med 2013; 369: 417 – 27.
dc.identifier.citedreferenceStone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al, for the International Network for the Study of the Systemic Vasculitides (INSSYS). A disease‐specific activity index for Wegener’s granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001; 44: 912 – 20.
dc.identifier.citedreferenceStone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA‐associated vasculitis. N Engl J Med 2010; 363: 221 – 32.
dc.identifier.citedreferenceLepse N, Land J, Rutgers A, Kallenberg CG, Stegeman CA, Abdulahad WH, et al. Toll‐like receptor 9 activation enhances B cell activating factor and interleukin‐21 induced anti‐proteinase 3 autoantibody production in vitro. Rheumatology (Oxford) 2016; 55: 162 – 72.
dc.identifier.citedreferenceBerti A, Cavalli G, Campochiaro C, Guglielmi B, Baldissera E, Cappio S, et al. Interleukin‐6 in ANCA‐associated vasculitis: rationale for successful treatment with tocilizumab. Semin Arthritis Rheum 2015; 45: 48 – 54.
dc.identifier.citedreferenceMonach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L, et al. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA‐associated vasculitis. Ann Rheum Dis 2013; 72: 1342 – 50.
dc.identifier.citedreferenceMonach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, et al. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheum 2011; 63: 3988 – 97.
dc.identifier.citedreferenceTanna A, Guarino L, Tam FW, Rodriquez‐Cubillo B, Levy JB, Cairns TD, et al. Long‐term outcome of anti‐neutrophil cytoplasm antibody‐associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant 2015; 30: 1185 – 92.
dc.identifier.citedreferenceFussner LA, Hummel AM, Schroeder DR, Silva F, Cartin‐Ceba R, Snyder MR, et al. Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3. Arthritis Rheumatol 2016; 68: 1700 – 10.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art40471_am.pdf
Size:
270.2KB
Format:
PDF
View/Open
Name:
art40471.pdf
Size:
425.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.